首页 > 最新文献

Practical Radiation Oncology最新文献

英文 中文
Quantitative Assessment of Full-Time Equivalent Effort for Kilovoltage-Cone Beam Computed Tomography Guided Online Adaptive Radiation Therapy for Medical Physicists. 医学物理学家 kV-CBCT 引导在线自适应 RT 的全职等效努力定量评估。
IF 3.4 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-18 DOI: 10.1016/j.prro.2024.08.007
Natalie N Viscariello, Kristen McConnell, Joseph Harms, Joel A Pogue, Xenia Ray, Eric Laugeman, Richard A Popple, Dennis N Stanley, Carlos E Cardenas

Purpose: With recent clinical adoption of online adaptive radiation therapy (oART) and the increased workload associated with adaptive radiation therapy (RT), proper staffing for medical physicists is paramount to safe clinical operation. However, there is currently no consensus on the full-time equivalent (FTE) requirements for safe administration of cone beam computed tomography (CBCT)-guided oART. This study aimed to quantitatively assess medical physics workload and staffing needs of a CBCT-guided oART program.

Methods and materials: We conducted a detailed analysis of the CBCT-guided adaptive planning and treatment workflows, encompassing tasks such as patient consultation, treatment planning, plan review, training, quality assurance, and treatment delivery. Using data from machine logs, clinical database queries, and staff surveys, we present a framework for estimating FTE values for different staffing scenarios, considering medical physicists' roles as planners, adaptors, or both.

Results: FTE calculations, based on an example workload of 100 adaptive and 200 nonadaptive patients per year, for 3 staffing scenarios were provided: medical physicists as planners and adaptors (2.9 FTE), medical physicists as planners but not adaptors (2.6 FTE), and medical physicists as adaptors but not planners (1.4 FTE). These findings offer calculation guidance and benchmarks for staffing requirements in CBCT-guided oART programs, emphasizing the need for specific staffing models to accommodate the complexities of adaptive RT.

Conclusions: This study outlines a framework for calculating FTE requirements for medical physicists in a CBCT-guided oART program. By analyzing the processes for 3 common adaptive RT workflows, this work can provide effective workforce planning and resource allocation estimates. This analysis can be used either before the implementation of an oART program, for program development, or as a review of current practices to ensure operational efficiency and proper staffing levels are maintained.

简介:最近,临床上开始采用在线自适应放疗,与自适应放疗相关的工作量也随之增加,因此,为医学物理学家配备适当的人员对于临床安全操作至关重要。然而,目前对 CBCT 引导的在线自适应放疗的安全管理所需的全职等效人员(FTE)还没有达成共识。本研究旨在定量评估 CBCT 引导的在线自适应放疗项目的医学物理工作量和人员需求:我们对 CBCT 引导的自适应计划和治疗工作流程进行了详细分析,其中包括患者咨询、治疗计划、计划审查、培训、质量保证和治疗实施等任务。利用来自机器日志、临床数据库查询和员工调查的数据,我们提出了一个框架,用于估算不同人员配置情况下的 FTE 值,同时考虑医学物理学家作为规划者、适应者或两者的角色:根据每年 100 名适应性患者和 200 名非适应性患者的工作量示例,提供了三种人员配置情况下的 FTE 计算结果:医学物理学家既是规划者又是适应者(2.9 FTE)、医学物理学家既是规划者又不是适应者(2.6 FTE)、医学物理学家既是适应者又不是规划者(1.4 FTE)。这些研究结果为 CBCT 引导的在线适应性放疗项目的人员需求提供了计算指导和基准,强调了特定人员配备模式的必要性,以适应适应性放疗的复杂性:本研究概述了 CBCT 引导的在线自适应放疗项目中对医学物理学家全职当量要求的计算框架。通过分析三种常见的适应性放射治疗工作流程,这项工作可以提供有效的劳动力规划和资源分配估算。这项分析既可以在实施在线自适应放射治疗计划之前使用,也可以用于计划开发,还可以作为对当前实践的回顾,以确保维持运行效率和适当的人员配置水平。
{"title":"Quantitative Assessment of Full-Time Equivalent Effort for Kilovoltage-Cone Beam Computed Tomography Guided Online Adaptive Radiation Therapy for Medical Physicists.","authors":"Natalie N Viscariello, Kristen McConnell, Joseph Harms, Joel A Pogue, Xenia Ray, Eric Laugeman, Richard A Popple, Dennis N Stanley, Carlos E Cardenas","doi":"10.1016/j.prro.2024.08.007","DOIUrl":"10.1016/j.prro.2024.08.007","url":null,"abstract":"<p><strong>Purpose: </strong>With recent clinical adoption of online adaptive radiation therapy (oART) and the increased workload associated with adaptive radiation therapy (RT), proper staffing for medical physicists is paramount to safe clinical operation. However, there is currently no consensus on the full-time equivalent (FTE) requirements for safe administration of cone beam computed tomography (CBCT)-guided oART. This study aimed to quantitatively assess medical physics workload and staffing needs of a CBCT-guided oART program.</p><p><strong>Methods and materials: </strong>We conducted a detailed analysis of the CBCT-guided adaptive planning and treatment workflows, encompassing tasks such as patient consultation, treatment planning, plan review, training, quality assurance, and treatment delivery. Using data from machine logs, clinical database queries, and staff surveys, we present a framework for estimating FTE values for different staffing scenarios, considering medical physicists' roles as planners, adaptors, or both.</p><p><strong>Results: </strong>FTE calculations, based on an example workload of 100 adaptive and 200 nonadaptive patients per year, for 3 staffing scenarios were provided: medical physicists as planners and adaptors (2.9 FTE), medical physicists as planners but not adaptors (2.6 FTE), and medical physicists as adaptors but not planners (1.4 FTE). These findings offer calculation guidance and benchmarks for staffing requirements in CBCT-guided oART programs, emphasizing the need for specific staffing models to accommodate the complexities of adaptive RT.</p><p><strong>Conclusions: </strong>This study outlines a framework for calculating FTE requirements for medical physicists in a CBCT-guided oART program. By analyzing the processes for 3 common adaptive RT workflows, this work can provide effective workforce planning and resource allocation estimates. This analysis can be used either before the implementation of an oART program, for program development, or as a review of current practices to ensure operational efficiency and proper staffing levels are maintained.</p>","PeriodicalId":54245,"journal":{"name":"Practical Radiation Oncology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142300801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiosurgery Society Case-Based Guide to Stereotactic Body Radiation Therapy for Challenging Cases of Spinal Metastases. 放射外科协会《针对脊柱转移瘤疑难病例的立体定向体放射治疗病例指南》。
IF 3.4 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-03 DOI: 10.1016/j.prro.2024.08.004
Khaled Aziz, Daniel Koffler, April Vassantachart, Abbas Rattani, Nii-Kwanchie Ankrah, Emile Gogineni, Therese Y Andraos, Arjun Sahgal, Balamurugan Vellayappan, Emma M Dunne, Shankar Siva, Fabio Y Moraes, Matthias Guckenberger, Daniel Lubelski, Samuel Chao, Stephanie Combs, Eric Chang, Anubhav G Amin, Matthew Foote, Iris Gibbs, Minsun Kim, Joshua Palmer, Simon Lo, Kristin J Redmond

Purpose: Spinal stereotactic body radiation therapy (SBRT) has become the standard of care in management of patients with limited sites of metastatic disease, radioresistant histologies, painful vertebral metastases with long life expectancy and cases of reirradiation. Our case-based guidelines aim to assist radiation oncologists in the appropriate utilization of SBRT for common, yet challenging, cases of spinal metastases.

Methods and materials: Cases were selected to include scenarios of large volume sacral disease with nerve entrapment, medically inoperable disease abutting the thecal sac, and local failure after prior SBRT. Relevant literature was reviewed, and areas requiring further investigation were discussed to offer a framework for evidence-based clinical practice.

Results: Spinal SBRT can be effectively delivered in challenging cases following multidisciplinary discussion by using a methodical approach to patient selection, appropriate dose selection, and adherence to evidence-based dose constraints.

Conclusions: The Radiosurgery Society's case-based practice review offers guidance to practicing physicians treating technically challenging SBRT candidate patients with spinal metastases.

目的:脊柱立体定向体放射治疗(SBRT)已成为治疗转移性疾病部位有限、放射抗性组织学、预期寿命长的疼痛性椎体转移以及再照射病例的标准治疗方法。我们基于病例的指南旨在帮助放射肿瘤专家在常见但具有挑战性的脊柱转移病例中适当使用 SBRT:我们选择的病例包括神经卡压的大体积骶骨疾病、与椎管囊相邻的医学上无法手术的疾病以及之前SBRT治疗局部失败的病例。对相关文献进行了回顾,并讨论了需要进一步研究的领域,为循证临床实践提供了一个框架:结果:经过多学科讨论,脊柱SBRT可以在具有挑战性的病例中有效实施,方法是有条不紊地选择患者、选择合适的剂量并遵守循证剂量限制:放射外科协会基于病例的实践评论为执业医师治疗具有技术难度的脊柱转移瘤 SBRT 候选患者提供了指导。
{"title":"Radiosurgery Society Case-Based Guide to Stereotactic Body Radiation Therapy for Challenging Cases of Spinal Metastases.","authors":"Khaled Aziz, Daniel Koffler, April Vassantachart, Abbas Rattani, Nii-Kwanchie Ankrah, Emile Gogineni, Therese Y Andraos, Arjun Sahgal, Balamurugan Vellayappan, Emma M Dunne, Shankar Siva, Fabio Y Moraes, Matthias Guckenberger, Daniel Lubelski, Samuel Chao, Stephanie Combs, Eric Chang, Anubhav G Amin, Matthew Foote, Iris Gibbs, Minsun Kim, Joshua Palmer, Simon Lo, Kristin J Redmond","doi":"10.1016/j.prro.2024.08.004","DOIUrl":"10.1016/j.prro.2024.08.004","url":null,"abstract":"<p><strong>Purpose: </strong>Spinal stereotactic body radiation therapy (SBRT) has become the standard of care in management of patients with limited sites of metastatic disease, radioresistant histologies, painful vertebral metastases with long life expectancy and cases of reirradiation. Our case-based guidelines aim to assist radiation oncologists in the appropriate utilization of SBRT for common, yet challenging, cases of spinal metastases.</p><p><strong>Methods and materials: </strong>Cases were selected to include scenarios of large volume sacral disease with nerve entrapment, medically inoperable disease abutting the thecal sac, and local failure after prior SBRT. Relevant literature was reviewed, and areas requiring further investigation were discussed to offer a framework for evidence-based clinical practice.</p><p><strong>Results: </strong>Spinal SBRT can be effectively delivered in challenging cases following multidisciplinary discussion by using a methodical approach to patient selection, appropriate dose selection, and adherence to evidence-based dose constraints.</p><p><strong>Conclusions: </strong>The Radiosurgery Society's case-based practice review offers guidance to practicing physicians treating technically challenging SBRT candidate patients with spinal metastases.</p>","PeriodicalId":54245,"journal":{"name":"Practical Radiation Oncology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive Clinical Usability-Oriented Contour Quality Evaluation for Deep Learning Auto-segmentation: Combining Multiple Quantitative Metrics Through Machine Learning. 用于深度学习自动分割的以临床可用性为导向的综合轮廓质量评估:通过机器学习结合多种定量指标。
IF 3.4 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-02 DOI: 10.1016/j.prro.2024.07.007
Ying Zhang, Asma Amjad, Jie Ding, Christina Sarosiek, Mohammad Zarenia, Renae Conlin, William A Hall, Beth Erickson, Eric Paulson

Purpose: The current commonly used metrics for evaluating the quality of auto-segmented contours have limitations and do not always reflect the clinical usefulness of the contours. This work aims to develop a novel contour quality classification (CQC) method by combining multiple quantitative metrics for clinical usability-oriented contour quality evaluation for deep learning-based auto-segmentation (DLAS).

Methods and materials: The CQC was designed to categorize contours on slices as acceptable, minor edit, or major edit based on the expected editing effort/time with supervised ensemble tree classification models using 7 quantitative metrics. Organ-specific models were trained for 5 abdominal organs (pancreas, duodenum, stomach, small, and large bowels) using 50 magnetic resonance imaging (MRI) data sets. Twenty additional MRI and 9 computed tomography (CT) data sets were employed for testing. Interobserver variation (IOV) was assessed among 6 observers and consensus labels were established through majority vote for evaluation. The CQC was also compared with a threshold-based baseline approach.

Results: For the 5 organs, the average area under the curve was 0.982 ± 0.01 and 0.979 ± 0.01, the mean accuracy was 95.8% ± 1.7% and 94.3% ± 2.1%, and the mean risk rate was 0.8% ± 0.4% and 0.7% ± 0.5% for MRI and CT testing data set, respectively. The CQC results closely matched the IOV results (mean accuracy of 94.2% ± 0.8% and 94.8% ± 1.7%) and were significantly higher than those obtained using the threshold-based method (mean accuracy of 80.0% ± 4.7%, 83.8% ± 5.2%, and 77.3% ± 6.6% using 1, 2, and 3 metrics).

Conclusions: The CQC models demonstrated high performance in classifying the quality of contour slices. This method can address the limitations of existing metrics and offers an intuitive and comprehensive solution for clinically oriented evaluation and comparison of DLAS systems.

目的:目前常用的自动分割轮廓质量评估指标存在局限性,并不总能反映轮廓的临床实用性。本研究旨在开发一种新颖的轮廓质量分类(CQC)方法,该方法结合了多种定量指标,用于基于深度学习的自动分割(DLAS)中以临床实用性为导向的轮廓质量评估:CQC 的设计目的是根据预期的编辑工作量/时间,利用七个量化指标的监督集合树分类模型,将切片上的轮廓分为可接受、小编辑或大编辑。使用 50 个 MRI 数据集为五个腹部器官(胰腺、十二指肠、胃、小肠和大肠)训练了特定器官模型。另外还使用了 20 个 MRI 数据集和 9 个 CT 数据集进行测试。对六位观察者的观察者间差异(IOV)进行了评估,并通过多数票确定了共识标签进行评估。CQC 还与基于阈值的基线方法进行了比较:对于五个器官,MRI 和 CT 测试数据集的平均 AUC 分别为 0.982±0.01 和 0.979±0.01,平均准确率分别为 95.8±1.7% 和 94.3±2.1%,平均风险率分别为 0.8±0.4% 和 0.7±0.5%。CQC结果与IOV结果(平均准确率为94.2±0.8%和94.8±1.7%)非常接近,并且明显高于使用基于阈值的方法所获得的结果(使用一个、两个和三个指标的平均准确率分别为80.0±4.7%、83.8±5.2%和77.3±6.6%):结论:CQC 模型在轮廓切片质量分类方面表现出很高的性能。这种方法可以解决现有指标的局限性,为临床导向的 DLAS 系统评估和比较提供了直观、全面的解决方案。
{"title":"Comprehensive Clinical Usability-Oriented Contour Quality Evaluation for Deep Learning Auto-segmentation: Combining Multiple Quantitative Metrics Through Machine Learning.","authors":"Ying Zhang, Asma Amjad, Jie Ding, Christina Sarosiek, Mohammad Zarenia, Renae Conlin, William A Hall, Beth Erickson, Eric Paulson","doi":"10.1016/j.prro.2024.07.007","DOIUrl":"10.1016/j.prro.2024.07.007","url":null,"abstract":"<p><strong>Purpose: </strong>The current commonly used metrics for evaluating the quality of auto-segmented contours have limitations and do not always reflect the clinical usefulness of the contours. This work aims to develop a novel contour quality classification (CQC) method by combining multiple quantitative metrics for clinical usability-oriented contour quality evaluation for deep learning-based auto-segmentation (DLAS).</p><p><strong>Methods and materials: </strong>The CQC was designed to categorize contours on slices as acceptable, minor edit, or major edit based on the expected editing effort/time with supervised ensemble tree classification models using 7 quantitative metrics. Organ-specific models were trained for 5 abdominal organs (pancreas, duodenum, stomach, small, and large bowels) using 50 magnetic resonance imaging (MRI) data sets. Twenty additional MRI and 9 computed tomography (CT) data sets were employed for testing. Interobserver variation (IOV) was assessed among 6 observers and consensus labels were established through majority vote for evaluation. The CQC was also compared with a threshold-based baseline approach.</p><p><strong>Results: </strong>For the 5 organs, the average area under the curve was 0.982 ± 0.01 and 0.979 ± 0.01, the mean accuracy was 95.8% ± 1.7% and 94.3% ± 2.1%, and the mean risk rate was 0.8% ± 0.4% and 0.7% ± 0.5% for MRI and CT testing data set, respectively. The CQC results closely matched the IOV results (mean accuracy of 94.2% ± 0.8% and 94.8% ± 1.7%) and were significantly higher than those obtained using the threshold-based method (mean accuracy of 80.0% ± 4.7%, 83.8% ± 5.2%, and 77.3% ± 6.6% using 1, 2, and 3 metrics).</p><p><strong>Conclusions: </strong>The CQC models demonstrated high performance in classifying the quality of contour slices. This method can address the limitations of existing metrics and offers an intuitive and comprehensive solution for clinically oriented evaluation and comparison of DLAS systems.</p>","PeriodicalId":54245,"journal":{"name":"Practical Radiation Oncology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134431","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Centralized Quality Assurance of Stereotactic Body Radiation Therapy for the Veterans Affairs Cooperative Studies Program Study Number 2005: A Phase 3 Randomized Trial of Lung Cancer Surgery or Stereotactic Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer (VALOR). 退伍军人事务合作研究计划研究编号 2005:立体定向体外放射治疗的集中质量保证:肺癌手术或立体定向放疗治疗可手术早期非小细胞肺癌的 3 期随机试验 (VALOR)。
IF 3.4 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-02 DOI: 10.1016/j.prro.2024.07.010
Timothy A Ritter, Robert D Timmerman, Hena I Hanfi, Hairong Shi, Matthew K Leiner, Hua Feng, Vicki L Skinner, Lisa M Robin, Cheryl Odle, Gabriella Amador, Tom Sindowski, Amanda J Snodgrass, Grant D Huang, Domenic J Reda, Christopher Slatore, Catherine R Sears, Lorraine D Cornwell, Tomer Z Karas, David H Harpole, Jatinder Palta, Drew Moghanaki

Purpose: The phase 3 Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy study implemented centralized quality assurance (QA) to mitigate risks of protocol deviations. This report summarizes the quality and compliance of the first 100 participants treated with stereotactic body radiation therapy (SBRT) in this study.

Methods and materials: A centralized QA program was developed to credential and monitor study sites to ensure standard-of-care lung SBRT treatments are delivered to participants. Requirements were adapted from protocols established by the National Cancer Institute's Image and Radiation Oncology Core, which provides oversight for clinical trials sponsored by the National Cancer Institute's National Clinical Trials Network.

Results: The first 100 lung SBRT treatment plans were reviewed from April 2017 to October 2022. Tumor contours were appropriate in all submissions. Planning target volume (PTV) expansions were less than the minimum 5 mm requirement in 2% of cases. Critical organ-at-risk structures were contoured accurately for the proximal bronchial tree, trachea, esophagus, spinal cord, and brachial plexus in 75%, 92%, 100%, 100%, and 95% of cases, respectively. Prescriptions were appropriate in 98% of cases; 2 central tumors were treated using a peripheral tumor dose prescription while meeting organ-at-risk constraints. PTV V100% (the percentage of target volume that receives 100% or more of the prescription) values were above the protocol-defined minimum of 94% in all but 1 submission. The median dose maximum (Dmax) within the PTV was 125.4% (105.8%-149.0%; SD ± 8.7%), where values reference the percentage of the prescription dose. High-dose conformality (ratio of the volume of the prescription isodose to the volume of the PTV) and intermediate-dose compactness [R50% (ratio of the volume of the half prescription isodose to the volume of the PTV) and D2cm (the maximum dose beyond a 2 cm expansion of the PTV expressed as a percentage of the prescription dose)] were acceptable or deviation acceptable in 100% and 94% of cases, respectively.

Conclusions: The first 100 participants randomized to SBRT in this study were appropriately treated without safety concerns. A response to the incorrect prescriptions led to preventative measures without further recurrences. The program was developed in a health care system without prior experience with a centralized radiation therapy QA program and may serve as a reference for other institutions.

背景:退伍军人事务部肺癌手术或立体定向放射治疗(VALOR)III 期研究实施了集中质量保证(QA),以降低方案偏差风险。本报告总结了在该研究中接受 SBRT 治疗的前 100 名参与者的质量和依从性:方法:制定了一项集中质量保证计划,对研究机构进行认证和监督,以确保为参与者提供符合标准的肺部立体定向体放射治疗(SBRT)。这些要求改编自美国国立癌症研究所图像与放射肿瘤学核心制定的协议,该核心负责监督由美国国立癌症研究所国家临床试验网络赞助的临床试验:从2017年4月到2022年10月,对首批100例肺SBRT治疗计划进行了审查。所有提交的肿瘤轮廓均合适。2%的病例的PTV扩展小于最低5毫米的要求。75%、92%、100%、100% 和 95% 的病例中,近端支气管树、气管、食管、脊髓和臂丛的关键风险器官 (OAR) 结构轮廓准确。在 98% 的病例中,处方都是适当的;有两个中心肿瘤在满足 OAR 限制的情况下,使用外周肿瘤剂量处方进行了治疗。除一个病例外,其他所有病例的 PTV V100% 值都高于方案定义的最低值 94%。PTV内Dmax的中位数为125.4%(105.8% - 149.0%,标准偏差±8.7%)。高剂量符合性(结论:本研究中随机接受 SBRT 治疗的前 100 名参与者均接受了适当的治疗,没有出现安全问题。针对错误处方采取了预防措施,没有再发生复发。该计划是在一个没有集中 RT QA 计划经验的医疗系统中制定的,可为其他机构提供参考。
{"title":"Centralized Quality Assurance of Stereotactic Body Radiation Therapy for the Veterans Affairs Cooperative Studies Program Study Number 2005: A Phase 3 Randomized Trial of Lung Cancer Surgery or Stereotactic Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer (VALOR).","authors":"Timothy A Ritter, Robert D Timmerman, Hena I Hanfi, Hairong Shi, Matthew K Leiner, Hua Feng, Vicki L Skinner, Lisa M Robin, Cheryl Odle, Gabriella Amador, Tom Sindowski, Amanda J Snodgrass, Grant D Huang, Domenic J Reda, Christopher Slatore, Catherine R Sears, Lorraine D Cornwell, Tomer Z Karas, David H Harpole, Jatinder Palta, Drew Moghanaki","doi":"10.1016/j.prro.2024.07.010","DOIUrl":"10.1016/j.prro.2024.07.010","url":null,"abstract":"<p><strong>Purpose: </strong>The phase 3 Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy study implemented centralized quality assurance (QA) to mitigate risks of protocol deviations. This report summarizes the quality and compliance of the first 100 participants treated with stereotactic body radiation therapy (SBRT) in this study.</p><p><strong>Methods and materials: </strong>A centralized QA program was developed to credential and monitor study sites to ensure standard-of-care lung SBRT treatments are delivered to participants. Requirements were adapted from protocols established by the National Cancer Institute's Image and Radiation Oncology Core, which provides oversight for clinical trials sponsored by the National Cancer Institute's National Clinical Trials Network.</p><p><strong>Results: </strong>The first 100 lung SBRT treatment plans were reviewed from April 2017 to October 2022. Tumor contours were appropriate in all submissions. Planning target volume (PTV) expansions were less than the minimum 5 mm requirement in 2% of cases. Critical organ-at-risk structures were contoured accurately for the proximal bronchial tree, trachea, esophagus, spinal cord, and brachial plexus in 75%, 92%, 100%, 100%, and 95% of cases, respectively. Prescriptions were appropriate in 98% of cases; 2 central tumors were treated using a peripheral tumor dose prescription while meeting organ-at-risk constraints. PTV V100% (the percentage of target volume that receives 100% or more of the prescription) values were above the protocol-defined minimum of 94% in all but 1 submission. The median dose maximum (Dmax) within the PTV was 125.4% (105.8%-149.0%; SD ± 8.7%), where values reference the percentage of the prescription dose. High-dose conformality (ratio of the volume of the prescription isodose to the volume of the PTV) and intermediate-dose compactness [R50% (ratio of the volume of the half prescription isodose to the volume of the PTV) and D2cm (the maximum dose beyond a 2 cm expansion of the PTV expressed as a percentage of the prescription dose)] were acceptable or deviation acceptable in 100% and 94% of cases, respectively.</p><p><strong>Conclusions: </strong>The first 100 participants randomized to SBRT in this study were appropriately treated without safety concerns. A response to the incorrect prescriptions led to preventative measures without further recurrences. The program was developed in a health care system without prior experience with a centralized radiation therapy QA program and may serve as a reference for other institutions.</p>","PeriodicalId":54245,"journal":{"name":"Practical Radiation Oncology","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142134430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Impact of Radiation Therapy in Patients with Systemic Sclerosis and Head and Neck Cancer 放疗对全身性硬化症和头颈部癌症患者的影响。
IF 3.4 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.prro.2024.04.015

Objective

Systemic sclerosis (SSc) is considered a relative, or in some cases, absolute contraindication for radiation therapy for various cancers; however, radiation is the standard of care and the best option for tumor control for locally advanced head and neck (H&N) cancer. We present a case series to document postradiation outcomes in patients with SSc and H&N cancer.

Methods

Patients with SSc and H&N cancer treated with radiation were identified from the Johns Hopkins Scleroderma Center and the University of Pittsburgh Scleroderma Center research registries. Through chart review, we identified whether patients developed predetermined acute and late side effects or changes in SSc activity from radiation. We further describe therapies used to prevent and treat radiation-induced fibrosis.

Results

Thirteen patients with SSc who received radiation therapy for H&N cancer were included. Five-year survival was 54%. Nine patients (69%) developed local radiation-induced skin thickening, and 7 (54%) developed reduced neck range of motion. Two patients required long-term percutaneous endoscopic gastrostomy use due to radiation therapy complications. No patients required respiratory support related to radiation therapy. Regarding SSc disease activity among the patients with established SSc before radiation therapy, none experienced interstitial lung disease progression in the postradiation period. After radiation, one patient had worsening skin disease outside the radiation field; however, this patient was within the first year of SSc, when progressive skin disease is expected. Treatment strategies to prevent radiation fibrosis included pentoxifylline, amifostine, and vitamin E, while intravenous immunoglobulin (IVIG) was used to treat it.

Conclusion

Although some patients with SSc who received radiation for H&N cancer developed localized skin thickening and reduced neck range of motion, systemic flares of SSc were uncommon. This observational study provides evidence to support the use of radiation therapy for H&N cancer in patients with SSc when radiation is the best treatment option.

目的:系统性硬化症(SSc)被认为是各种癌症放射治疗的相对禁忌症,在某些情况下甚至是绝对禁忌症;然而,放射治疗是局部晚期头颈部癌症(H&N)的标准治疗方法和控制肿瘤的最佳选择。我们提供了一个病例系列,记录了 SSc 和 H&N 癌症患者放疗后的疗效:方法:我们从两个大型硬皮病中心研究登记处找到了接受放射治疗的 SSc 和 H&N 癌症患者。通过病历审查,我们确定了患者是否因放射治疗而出现预先确定的急性和晚期副作用或 SSc 活性变化。我们进一步描述了用于预防和治疗辐射诱导的纤维化的疗法:共纳入了 13 名接受 H&N 癌症放射治疗的 SSc 患者。五年生存率为 54%。九名患者(69%)出现了局部放射引起的皮肤增厚,七名患者(54%)出现了颈部活动范围减小。两名患者因放疗并发症而需要长期使用经皮内镜胃造瘘术。没有患者因放疗而需要呼吸支持。关于放疗前已确诊的 SSc 患者的 SSc 疾病活动情况,没有人在放疗后出现间质性肺病进展。放射治疗后,一名患者在放射野外的皮肤病恶化,但这名患者是在 SSc 第一年内,皮肤病进展是意料之中的。预防放射性纤维化的治疗策略包括喷托维林、阿米福星和维生素E,而静脉注射免疫球蛋白(IVIG)则用于治疗放射性纤维化:虽然一些接受 H&N 癌症放射治疗的 SSc 患者会出现局部皮肤增厚和颈部活动范围减小的情况,但 SSc 全身性复发的情况并不常见。这项观察性研究为SSc患者使用放射治疗H&N癌提供了证据,如果放射治疗是最佳治疗方案的话。
{"title":"The Impact of Radiation Therapy in Patients with Systemic Sclerosis and Head and Neck Cancer","authors":"","doi":"10.1016/j.prro.2024.04.015","DOIUrl":"10.1016/j.prro.2024.04.015","url":null,"abstract":"<div><h3>Objective</h3><p>Systemic sclerosis (SSc) is considered a relative, or in some cases, absolute contraindication for radiation therapy for various cancers; however, radiation is the standard of care and the best option for tumor control for locally advanced head and neck (H&amp;N) cancer. We present a case series to document postradiation outcomes in patients with SSc and H&amp;N cancer.</p></div><div><h3>Methods</h3><p>Patients with SSc and H&amp;N cancer treated with radiation were identified from the Johns Hopkins Scleroderma<span><span> Center and the University of Pittsburgh Scleroderma Center research registries. Through chart review, we identified whether patients developed predetermined acute and late side effects or changes in SSc activity from radiation. We further describe therapies used to prevent and treat radiation-induced </span>fibrosis.</span></p></div><div><h3>Results</h3><p><span>Thirteen patients with SSc who received radiation therapy for H&amp;N cancer were included. Five-year survival was 54%. Nine patients (69%) developed local radiation-induced skin thickening, and 7 (54%) developed reduced neck range of motion. Two patients required long-term percutaneous endoscopic gastrostomy<span> use due to radiation therapy complications. No patients required respiratory support<span> related to radiation therapy. Regarding SSc disease activity among the patients with established SSc before radiation therapy, none experienced interstitial lung </span></span></span>disease progression<span><span><span> in the postradiation period. After radiation, one patient had worsening skin disease outside the radiation field; however, this patient was within the first year of SSc, when progressive skin disease is expected. Treatment strategies to prevent radiation fibrosis included </span>pentoxifylline<span>, amifostine, and </span></span>vitamin E, while intravenous immunoglobulin (IVIG) was used to treat it.</span></p></div><div><h3>Conclusion</h3><p>Although some patients with SSc who received radiation for H&amp;N cancer developed localized skin thickening and reduced neck range of motion, systemic flares of SSc were uncommon. This observational study provides evidence to support the use of radiation therapy for H&amp;N cancer in patients with SSc when radiation is the best treatment option.</p></div>","PeriodicalId":54245,"journal":{"name":"Practical Radiation Oncology","volume":"14 5","pages":"Pages e334-e343"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140864403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Masthead/Sub page 刊头/分页
IF 3.4 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-01 DOI: 10.1016/S1879-8500(24)00168-1
{"title":"Masthead/Sub page","authors":"","doi":"10.1016/S1879-8500(24)00168-1","DOIUrl":"10.1016/S1879-8500(24)00168-1","url":null,"abstract":"","PeriodicalId":54245,"journal":{"name":"Practical Radiation Oncology","volume":"14 5","pages":"Page A1"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142096577","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
To pass away on leap day 在闰日去世。
IF 3.4 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.prro.2024.01.008
{"title":"To pass away on leap day","authors":"","doi":"10.1016/j.prro.2024.01.008","DOIUrl":"10.1016/j.prro.2024.01.008","url":null,"abstract":"","PeriodicalId":54245,"journal":{"name":"Practical Radiation Oncology","volume":"14 5","pages":"Pages 368-370"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140121335","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Radiation Therapy Contouring Atlas for Delineation of the Level I and II Axillae in the Prone Position: A Single-Institution Experience 用于在俯卧位划定 I-II 级腋窝的放射治疗轮廓图:单个机构的经验。
IF 3.4 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.prro.2024.04.016

Purpose

With transition from supine to prone position, tenting of the pectoralis major occurs, displacing the muscle from the chest wall and shifting the level I and II axillary spaces. For patients for whom we aim to treat the level I and II axillae using the prone technique, accurate delineation of these nodal regions is necessary. Although different consensus guidelines exist for delineation of nodal anatomy in supine position, to our knowledge, there are no contouring guidelines in the prone position that account for this change in nodal anatomy.

Methods and Materials

The level I and II nodal contours from the Radiation Therapy Oncology Group (RTOG) breast cancer supine atlas were adapted for prone position by 2 radiation oncologists and a breast radiologist based on anatomic changes observed from supine to prone positioning on preoperative diagnostic imaging. Forty-three patients from a single institution treated with prone high tangents from 2012 to 2018 were identified as representative cases to delineate the revised level I and II axillae on noncontrast computed tomography (CT) scans obtained during radiation simulation. The revised nodal contours were reviewed by an expanded expert multidisciplinary panel including breast radiologists, radiation oncologists, and surgical oncologists for consistency and reproducibility.

Results

Consensus was achieved among the panel in order to create modifications from the RTOG breast atlas for CT–based contouring of the level I and II axillae in prone position using bone, muscle, and skin as landmarks. This atlas provides representative examples and accompanying descriptions for the changes described to the caudal and anterior borders of level II and the anterior, posterior, medial, and lateral borders of level I. A step-by-step guide is provided for properly identifying the revised anterior border of the level I axilla.

Conclusions

The adaptations to the RTOG breast cancer atlas for prone positioning will enable radiation oncologists to more accurately target the level I and II axillae when the axillae are targets in addition to the breast.

目的:从仰卧位转为俯卧位时,胸大肌会出现帐篷,使肌肉从胸壁移位,并移动 I-II 级腋窝间隙。对于我们打算使用俯卧位技术治疗 I-II 级腋窝的患者来说,准确划分这些结节区域是非常必要的。虽然仰卧位结节解剖的划定有不同的共识指南,但据我们所知,还没有俯卧位的轮廓划定指南考虑到结节解剖的这种变化:两位放射肿瘤专家和一位乳腺放射专家根据术前诊断成像中观察到的从仰卧位到俯卧位的解剖变化,对乳腺癌放射治疗肿瘤学组(RTOG)仰卧位图谱中的 I-II 级结节轮廓进行了调整,使其适用于俯卧位。从 2012 年到 2018 年,来自一家机构的 43 例采用俯卧位高切线治疗的患者被确定为代表性病例,以便在放射模拟期间获得的非对比计算机断层扫描(CT)上划定修订后的 I-II 级腋窝。包括乳腺放射科医生、放射肿瘤科医生和肿瘤外科医生在内的多学科扩大专家小组对修订后的结节轮廓进行了审查,以确保一致性和可重复性:结果:专家小组达成共识,对 RTOG 乳腺图谱进行修改,以骨骼、肌肉和皮肤为地标,绘制出基于 CT 的 I-II 级腋窝俯卧轮廓图。该图谱为 II 级腋窝的尾缘和前缘以及 I 级腋窝的前缘、后缘、内侧缘和外侧缘所作的修改提供了代表性示例和附带说明:对 RTOG 乳腺癌图谱进行俯卧位调整后,当腋窝是乳房以外的目标时,放射肿瘤学家就能更准确地瞄准 I-II 级腋窝。
{"title":"A Radiation Therapy Contouring Atlas for Delineation of the Level I and II Axillae in the Prone Position: A Single-Institution Experience","authors":"","doi":"10.1016/j.prro.2024.04.016","DOIUrl":"10.1016/j.prro.2024.04.016","url":null,"abstract":"<div><h3>Purpose</h3><p><span>With transition from supine to prone position, tenting of the pectoralis major occurs, displacing the muscle from the chest wall and shifting the level I and II axillary spaces. For patients for whom we aim to treat the level I and II </span>axillae<span><span> using the prone technique, accurate delineation of these nodal regions is necessary. Although different consensus guidelines exist for delineation of nodal anatomy in </span>supine position, to our knowledge, there are no contouring guidelines in the prone position that account for this change in nodal anatomy.</span></p></div><div><h3>Methods and Materials</h3><p>The level I and II nodal contours from the Radiation Therapy Oncology<span> Group (RTOG) breast cancer supine atlas were adapted for prone position by 2 radiation oncologists and a breast radiologist based on anatomic changes observed from supine to prone positioning on preoperative diagnostic imaging. Forty-three patients from a single institution treated with prone high tangents from 2012 to 2018 were identified as representative cases to delineate the revised level I and II axillae on noncontrast computed tomography (CT) scans obtained during radiation simulation. The revised nodal contours were reviewed by an expanded expert multidisciplinary panel including breast radiologists, radiation oncologists, and surgical oncologists for consistency and reproducibility.</span></p></div><div><h3>Results</h3><p>Consensus was achieved among the panel in order to create modifications from the RTOG breast atlas for CT–based contouring of the level I and II axillae in prone position using bone, muscle, and skin as landmarks. This atlas provides representative examples and accompanying descriptions for the changes described to the caudal and anterior borders of level II and the anterior, posterior, medial, and lateral borders of level I. A step-by-step guide is provided for properly identifying the revised anterior border of the level I axilla.</p></div><div><h3>Conclusions</h3><p>The adaptations to the RTOG breast cancer atlas for prone positioning will enable radiation oncologists to more accurately target the level I and II axillae when the axillae are targets in addition to the breast.</p></div>","PeriodicalId":54245,"journal":{"name":"Practical Radiation Oncology","volume":"14 5","pages":"Pages 426-434"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140905189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiation Oncology Ransomware Attack Response Risk Analysis Using Failure Modes and Effects Analysis 利用 FMEA 进行放射肿瘤学勒索软件攻击响应风险分析。
IF 3.4 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.prro.2024.03.001

Purpose

There have been numerous significant ransomware attacks impacting Radiation Oncology in the past 5 years. Research into ransomware attack response in Radiation Oncology has consisted of case reports and descriptive articles and has lacked quantitative studies. The purpose of this work was to identify the significant safety risks to patients being treated with radiation therapy during a ransomware attack scenario, using Failure Modes and Effects Analysis.

Methods and Materials

A multi-institutional and multidisciplinary team conducted a Failure Modes and Effects Analysis by developing process maps and using Risk Priority Number (RPN) scores to quantify the increased likelihood of incidents in a ransomware attack scenario. The situation that was simulated was a ransomware attack that had removed the capability to access the Record and Verify (R&V) system. Five situations were considered: 1) a standard treatment of a patient with and without an R&V, 2) a standard treatment of a patient for the first fraction right after the R&V capabilities are disabled, and 3) 3 situations in which a plan modification was required. RPN scores were compared with and without R&V functionality.

Results

The data indicate that RPN scores increased by 71% (range, 38%-96%) when R&V functionality is disabled compared with a nonransomware attack state where R&V functionality is available. The failure modes with the highest RPN in the simulated ransomware attack state included incorrectly identifying patients on treatment, incorrectly identifying where a patient is in their course of treatment, treating the incorrect patient, and incorrectly tracking delivered fractions.

Conclusions

The presented study quantifies the increased risk of incidents when treating in a ransomware attack state, identifies key failure modes that should be prioritized when preparing for a ransomware attack, and provides data that can be used to guide future ransomware resiliency research.

简介:在过去 5 年中,发生了多起影响放射肿瘤学的重大勒索软件攻击事件。有关放射肿瘤学应对勒索软件攻击的研究主要是案例报告和描述性文章,缺乏定量研究。这项工作的目的是利用故障模式与影响分析(FMEA)确定在勒索软件攻击情况下接受放射治疗的患者所面临的重大安全风险:一个多机构、多学科团队通过绘制流程图和使用风险优先级号(RPN)评分来量化勒索软件攻击情景下发生事故的可能性,从而进行了故障模式和影响分析。模拟的情况是,勒索软件攻击使记录与验证 (R&V) 系统无法访问。共考虑了五种情况:1)在有和没有 R&V 的情况下对病人进行标准治疗;2)在 R&V 功能被禁用后对病人进行第一部分的标准治疗;3)需要修改计划的三种情况。结果显示,有和没有 R&V 功能时的 RPN 得分进行了比较:结果:数据显示,与具备 R&V 功能的非勒索软件攻击状态相比,当 R&V 功能被禁用时,RPN 分数增加了 71%(范围为 38-96%)。在模拟勒索软件攻击状态下,RPN 最高的故障模式包括:错误识别正在接受治疗的患者、错误识别患者在治疗过程中的位置、治疗不正确的患者以及错误跟踪交付的分数:本研究量化了在勒索软件攻击状态下进行治疗所增加的事故风险,确定了在准备应对勒索软件攻击时应优先考虑的关键故障模式,并提供了可用于指导未来勒索软件恢复能力研究的数据。
{"title":"Radiation Oncology Ransomware Attack Response Risk Analysis Using Failure Modes and Effects Analysis","authors":"","doi":"10.1016/j.prro.2024.03.001","DOIUrl":"10.1016/j.prro.2024.03.001","url":null,"abstract":"<div><h3>Purpose</h3><p>There have been numerous significant ransomware attacks impacting Radiation Oncology in the past 5 years. Research into ransomware attack response in Radiation Oncology has consisted of case reports and descriptive articles and has lacked quantitative studies. The purpose of this work was to identify the significant safety risks to patients being treated with radiation therapy during a ransomware attack scenario, using Failure Modes and Effects Analysis.</p></div><div><h3>Methods and Materials</h3><p>A multi-institutional and multidisciplinary team conducted a Failure Modes and Effects Analysis by developing process maps and using Risk Priority Number (RPN) scores to quantify the increased likelihood of incidents in a ransomware attack scenario. The situation that was simulated was a ransomware attack that had removed the capability to access the Record and Verify (R&amp;V) system. Five situations were considered: 1) a standard treatment of a patient with and without an R&amp;V, 2) a standard treatment of a patient for the first fraction right after the R&amp;V capabilities are disabled, and 3) 3 situations in which a plan modification was required. RPN scores were compared with and without R&amp;V functionality.</p></div><div><h3>Results</h3><p>The data indicate that RPN scores increased by 71% (range, 38%-96%) when R&amp;V functionality is disabled compared with a nonransomware attack state where R&amp;V functionality is available. The failure modes with the highest RPN in the simulated ransomware attack state included incorrectly identifying patients on treatment, incorrectly identifying where a patient is in their course of treatment, treating the incorrect patient, and incorrectly tracking delivered fractions.</p></div><div><h3>Conclusions</h3><p>The presented study quantifies the increased risk of incidents when treating in a ransomware attack state, identifies key failure modes that should be prioritized when preparing for a ransomware attack, and provides data that can be used to guide future ransomware resiliency research.</p></div>","PeriodicalId":54245,"journal":{"name":"Practical Radiation Oncology","volume":"14 5","pages":"Pages e407-e415"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140177682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Like a Glove: Dose Dependent Magnetic Resonance Signal Changes Following Liver Stereotactic Body Radiation Therapy in the Setting of Hemochromatosis 像手套一样血色素沉着症患者接受肝脏立体定向体放射治疗后的剂量依赖性磁共振信号变化。
IF 3.4 3区 医学 Q2 ONCOLOGY Pub Date : 2024-09-01 DOI: 10.1016/j.prro.2024.04.005
{"title":"Like a Glove: Dose Dependent Magnetic Resonance Signal Changes Following Liver Stereotactic Body Radiation Therapy in the Setting of Hemochromatosis","authors":"","doi":"10.1016/j.prro.2024.04.005","DOIUrl":"10.1016/j.prro.2024.04.005","url":null,"abstract":"","PeriodicalId":54245,"journal":{"name":"Practical Radiation Oncology","volume":"14 5","pages":"Pages 361-362"},"PeriodicalIF":3.4,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140762784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Practical Radiation Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1